23 Oct 2026
2 days ago
101 views
Associate Health Minister David Seymour has today welcomed Pharmac’s decision to extend the 12-month transitional access funding limit for Pertuzumab with trastuzumab (Phesgo) for people receiving treatment for certain types of breast cancer in private clinics. “In the past, when Pharmac funded a new cancer treatment, people already paying for that treatment privately are forced to make a very difficult choice: spend their savings to continue private treatment undisrupted, or transfer to a public hospital. The latter can be detrimental to their recovery,” Mr Seymour says.
02 Oct 2026
3 weeks ago
346 views
Pharmac and Health New Zealand are expanding the range of funded medicines community pharmacies can provide without a prescription, including treatments for children’s skin conditions, oral thrush, vaginal thrush, and selected oral contraceptives. This initiative aims to improve timely access to healthcare, especially for rural and remote communities, reduce pressure on the health system, and lower primary care costs for families. Ministers David Seymour and Simeon Brown emphasize that utilizing pharmacists’ skills and pharmacies’ accessibility supports the government’s commitment to delivering quality healthcare close to home.
04 Sep 2026
1 month ago
525 views
Associate Health Minister David Seymour welcomes Medsafe’s approval for two psychiatrists to prescribe pharmaceutical grade MDMA for treating PTSD through psychedelic-assisted therapy, aligning New Zealand with Australia’s clinical practices. MDMA remains unapproved as a medicine, but strict safeguards and comprehensive clinical assessments ensure its safe and appropriate use within a controlled therapeutic setting, with no take-home dispensing allowed. This approval is specific to the two psychiatrists, requiring other clinicians to obtain separate Medsafe authorization, reflecting a commitment to expanding access to innovative treatments responsibly.
01 Sep 2026
1 month ago
449 views
Associate Health Minister David Seymour and Health Minister Simeon Brown welcome Pharmac’s decision to immediately fund flu vaccines for children aged 6 months to under five years, advancing the original 2027 timeline in response to public demand. This move aims to alleviate pressure on New Zealand’s health system amid the worst flu season in a decade, which has caused a sharp surge in hospitalizations and strained emergency departments. Vaccinating young children not only reduces their risk of severe illness and hospitalization but also helps curb transmission within households and the wider community.
26 Aug 2026
2 months ago
606 views
Associate Health Minister David Seymour welcomes Pharmac’s decision to fund flu vaccines for children aged six months to five years starting in April 2027, expanding coverage to over 260,000 children and improving protection with newer vaccine brands. This initiative aims to reduce the impact of flu on families, ease pressure on the health system during winter, and is part of a broader vaccine investment benefiting 1.6 million New Zealanders. The decision reflects strong public support for wider access to innovative vaccines and aligns with Pharmac’s goal of funding medicines based on community needs to improve health outcomes.
19 Aug 2026
2 months ago
622 views
Associate Health Minister David Seymour praises Pharmac’s progress in responding to the 2025/26 Letter of Expectations, highlighting improvements in patient involvement, timeliness of decision-making, and sector collaboration. Key achievements include trialling streamlined assessment pathways, enhancing consumer engagement, updating rare disorder policies, and advancing digital investments, all contributing to a clear multi-year organisational improvement programme. While progress is noted as impressive and transparency has increased, Seymour emphasizes that continued efforts to listen to patients and improve access to medicines remain essential.
05 Aug 2026
2 months ago
604 views
Associate Health Minister David Seymour welcomes Pharmac’s decision to expand access to type 2 diabetes medicines based on clinical need, benefiting over 30,000 patients regardless of ethnicity. From 1 September, medicines like empagliflozin and liraglutide will be funded for anyone with high blood sugar despite other treatments, removing previous restrictions related to cardiovascular or renal conditions. This change, supported by community feedback and a new supplier agreement, aims to improve health outcomes, reduce complications, and optimize health budget efficiency.
04 Aug 2026
2 months ago
608 views
Pharmac is enhancing its engagement with the patient community by establishing a new Community and Patient Advisory Committee (CPAC) to replace existing advisory groups, ensuring patients have a stronger voice in decision-making. This initiative builds on a cultural shift led by new leadership, supported by increased funding and expanded access to medicines benefiting hundreds of thousands of New Zealanders. Recruitment for CPAC members begins in October, with an interim committee guiding its development and implementation ahead of its official launch in the new year.
30 Jun 2026
3 months ago
841 views
Associate Health Minister David Seymour supports Pharmac’s proposal to remove all eligibility criteria for Rosuvastatin access from October 2026, allowing clinicians to prescribe it based on clinical need regardless of ethnicity. This change aims to improve management of high cholesterol, reduce heart attack and stroke risks, and is expected to increase the number of users by up to 108,000 over five years without affecting current patients. Pharmac will fund this expansion through savings from its 2025/26 Annual Tender, reflecting strong support from health professionals and consumers for timely access to the medicine.
26 Jun 2026
4 months ago
939 views
Associate Health Minister David Seymour has outlined clear expectations for Pharmac to deliver medicines and medical technology efficiently within its fixed budget, emphasizing the need for continued patient-focused processes, improved transparency, and enhanced collaboration with stakeholders. Pharmac has made significant progress by changing its culture, strengthening consumer and supplier partnerships, and improving access to medicines, supported by the Government’s largest-ever budget allocation of $7.2 billion over four years. Despite achievements, including funding decisions benefiting over 680,000 patients, Seymour stresses that ongoing efforts are needed to listen to patients and advance Pharmac’s long-term improvement programme.
09 Jun 2026
4 months ago
895 views
Associate Health Minister David Seymour supports Pharmac’s new responsibility to fund ambulance medicines from July 1, aiming to provide consistent access to emergency medicines nationwide while achieving cost savings. Following public consultation, Pharmac added seven commonly used ambulance medicines to the funded list to better reflect practical needs and improve patient outcomes. This change integrates ambulance medicines management with hospital medicines, enhancing system efficiency, value for taxpayers, and seamless care transitions between ambulance and hospital services.
28 May 2026
5 months ago
1135 views
The New Zealand Government is investing a record $5.8 billion in Budget 2026 to improve healthcare access, reduce wait times, and strengthen frontline services, raising total health spending to $34.2 billion in 2026/27. This funding supports increased care delivery across various sectors, including elective surgeries, cancer treatments, mental health services, and aged care, alongside initiatives like paediatric palliative care and enhanced digital health security. Additionally, structural changes such as removing the capital charge for Health New Zealand aim to improve efficiency without affecting patient care or overall service delivery.
27 May 2026
5 months ago
940 views
The second annual Minister for Manufacturing Awards in New Zealand celebrated businesses and individuals driving innovation, growth, and resilience in the manufacturing sector, which contributes $22 billion annually and 60% of goods exports to the economy. Winners included Architectural Glass Products for process innovation and manufacturing excellence, Devin Gibson as Apprentice of the Year, Oliver Hunt for healthcare remanufacturing leadership, and Jeff Douglas for his transformative legacy in pharmaceutical manufacturing. The awards highlight the sector's commitment to innovation, skills development, sustainable practices, and global competitiveness amid ongoing challenges.
21 May 2026
5 months ago
927 views
Associate Health Minister David Seymour supports Pharmac’s proposal to expand New Zealand’s vaccine program by funding flu vaccines for children aged 6 months to 5 years and securing supply for 17 vaccines and one diagnostic test. The proposal includes changing vaccine brands to enhance protection, particularly for older adults and at-risk groups, and aims to make over 1.5 million people eligible for funded vaccines in the first year. Pharmac is seeking public and professional feedback before finalizing the proposal, with changes expected to take effect from April and July 2027.
14 May 2026
5 months ago
971 views
Associate Health Minister David Seymour and Health Minister Simeon Brown support Pharmac’s proposal to expand funding for three type 2 diabetes medicines by removing ethnicity-based criteria and lowering cardiovascular risk thresholds, aiming to improve access based on clinical need. If approved, the changes could benefit up to 23,000 more people over five years, enhancing early treatment to reduce complications and hospital admissions. This initiative aligns with the Government’s broader commitment to equitable, needs-based healthcare and increased health system funding to improve outcomes for all New Zealanders.